Theophylline Tablet, Extended Release
Product Images NDC 46708-025

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 46708-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

300 mg 30" Hdpe Bottle (Theophylline 300mg)

This is a description of a medication for Theophylline in extended-release tablets. Each package contains 30 tablets with 300mg of Theophylline (Anhydrous) USP. Usual Dosage is provided in the package insert. The manufacturer of the medication is Alembic Pharmaceuticals Limited, located in Gujarat, India. The medication should be stored at a controlled room temperature of 20°-25° C (68°-77° F) and dispensed in a well-closed, child-resistant container. The NDC code is 46708-025-30, and the manufacturing license number is G/959.*

FDA Label Image

450 mg 30" Hdpe Bottle (Theophylline 450mg)

This is a medication packaging for Theophylline extended-release tablets. Each uncoated tablet contains 450mg of Theophylline(Anhydrous) USP. The product is manufactured by Alembic Pharmaceuticals Limited and should be stored at 20-25°C. It is recommended to consult the package insert for the usual dosage. The tablets should be dispensed in a well-closed container with a child-resistant closure as defined in the USP. The NDC number of the product is 46708-026-30 and it comes in a pack of 30 tablets.*

FDA Label Image

Structure (Theophylline Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.